Your browser doesn't support javascript.
loading
Neuro-ophthalmic manifestations of Ehlers-Danlos syndrome.
Rachapudi, Sruti S; Laylani, Noor A; Davila-Siliezar, Pamela A; Lee, Andrew G.
Afiliação
  • Rachapudi SS; University of Texas Medical Branch, Galveston.
  • Laylani NA; Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas.
  • Davila-Siliezar PA; Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas.
  • Lee AG; Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas.
Curr Opin Ophthalmol ; 34(6): 476-480, 2023 Nov 01.
Article em En | MEDLINE | ID: mdl-37729660
ABSTRACT
PURPOSE OF REVIEW To review the neuro-ophthalmic manifestations of Ehlers-Danlos syndrome (EDS). RECENT

FINDINGS:

Ehlers-Danlos syndrome (EDS) is a rare genetic disorder with an estimated prevalence of 1 in 5000 individuals, but its true prevalence may be underestimated because of variable clinical presentations and limited awareness among healthcare professionals. The neuro-ophthalmic features of EDS may be difficult to recognize in context but new molecular genetic testing is now available for identification of specific subtypes of EDS.

SUMMARY:

Ophthalmic manifestations of EDS include loss of vision and double vision (strabismus), high myopia, retinal detachment, and blue sclera. The vascular subtype of EDS can present as a carotid-cavernous fistula, intracranial aneurysm, or arterial dissection.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Ehlers-Danlos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Ehlers-Danlos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article